Copyright
©2013 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Hepatol. Aug 27, 2013; 5(8): 417-424
Published online Aug 27, 2013. doi: 10.4254/wjh.v5.i8.417
Published online Aug 27, 2013. doi: 10.4254/wjh.v5.i8.417
Imaging appearance of treated hepatocellular carcinoma
Francesco Agnello, Giuseppe Salvaggio, Roberto Lagalla, Massimo Midiri, Giuseppe Brancatelli, Section of Radiological Sciences, DIBIMEF, University of Palermo, 90127 Palermo, Italy
Giuseppe Cabibbo, Marcello Maida, Section of Gastroenterology, DIBIMIS, University of Palermo, 90100 Palermo, Italy
Author contributions: Agnello F, Salvaggio G, Cabibbo G and Brancatelli G were guarantors of integrity of entire study; Agnello F, Salvaggio G and Brancatelli G contributed to the manuscript drafting and manuscript revision for important intellectual content; Brancatelli G, Cabibbo G and Maida M contributed to the manuscript editing; all authors contributed to clinical studies, literature research and approval of final version of submitted manuscript.
Correspondence to: Giuseppe Cabibbo, MD, PhD, Section of Gastroenterology, DIBIMIS, University of Palermo, Palermo/IT, Piazza delle Cliniche 2, 90127 Palermo, Italy. g.cab@libero.it
Telephone: +39-91-6552280 Fax: +39-91-6552156
Received: May 17, 2013
Revised: July 4, 2013
Accepted: August 12, 2013
Published online: August 27, 2013
Processing time: 126 Days and 6.8 Hours
Revised: July 4, 2013
Accepted: August 12, 2013
Published online: August 27, 2013
Processing time: 126 Days and 6.8 Hours
Core Tip
Core tip: Surgical resection and imaging guided treatments play a crucial role in the management of hepatocellular carcinoma (HCC). Moreover, recent studies have underlined the potential of antiangiogenetic treatment in patients with untreatable, unresectable HCCs. The purpose of this article is to review HCC imaging appearance after treatment.